Estimating the excess lifetime risk of radiation induced secondary malignancy (SMN) in pediatric patients treated with craniospinal irradiation (CSI): Conventional radiation therapy versus helical intensity modulated radiation therapy

详细信息    查看全文

• 作者：Jordan A. Holmes ; MD^a ; Bhishamjit S. Chera ; MD^a ; ^b ; ^{bchera@med.unc.edu} ; David J. Brenner ; PhD ; DSc^c ; Igor Shuryak ; MD ; PhD^c ; Adam K. Wilson ; MD^a ; Misty Lehman-Davis ; CMD^a ; David V. Fried ; PhD^a ; Vivek Somasundaram ; BS^a ; Jun Lian ; PhD^a ; Tim Cullip ; MS^a ; Lawrence B. Marks ; MD^a ; ^b
• 刊名：Practical Radiation Oncology
• 出版年：2017
• 出版时间：January-February 2017
• 年：2017
• 卷：7
• 期：1
• 页码：35-41
• 全文大小：223 K
• 卷排序：7

文摘

To quantify the risk of radiation-induced second malignancies (SMN) in pediatric patients receiving craniospinal irradiation (CSI) either with 3-dimensional conformal radiation therapy (Conv CSI) or tomotherapy helical intensity modulated radiation therapy (Tomo CSI).Methods and materialsA novel predictive model that accounts for short- and long-term carcinogenesis was incorporated into our institutional treatment planning system to quantify the lifetime risk of SMN in incidentally irradiated organs. Five pediatric patients previously treated with CSI were studied. For each case, Conv CSI and Tomo CSI plans were computed. The excess absolute number of SMN was computed for each plan for each patient. For female patients, age was varied to assess its impact.ResultsTomo CSI has a much higher risk than Conv CSI for breast cancer. Tomo has a slightly increased risk for the lung, and conventional has a slightly higher risk for the thyroid. Both techniques have intermediate risks to the pancreas and stomach, and lesser risks to the bladder and rectum. For the breast, the magnitude of the absolute risks varied with age: 14.2% versus 7.4% (Tomo vs Conv) age 5; 16.9% versus 7.6% age 10, and 18.6% versus 8.0% age 15.ConclusionsTomo has a higher risk for inducing breast and lung second cancers, and when using Tomo-based intensity modulated radiation therapy, care should be taken to avoid incidental radiation to the breast. When planning CSI, one needs to balance these cancer risks against other normal tissue effects.